Science behind Nutraceuticals

Newsletter Archive

Our association sends out a digital newsletter about news regarding of neutraceuticals to its members once a month. Non-members can be kept posted through a RSS feed.




Newsletter 07/2013

New initiative against Hidden Hunger

Reduction of risk of breast cancer through marine n-3 PUFA

Eating one portion of fatty fish every week could halve the risk of developing rheumatoid arthritis




Reduction of risk of breast cancer through marine n-3 PUFA

A recent meta-analysis* published in the June 2013 edition of the British Medical Journal showed a significant 14% reduction of risk of breast cancer associated with n-3 PUFA intake (but no significant association was observed for fish intake or exposure to alpha linolenic acid).
The meta-analysis included twenty six publications, including 20 905 cases of breast cancer and 883 585 participants from 21 independent prospective cohort studies.
Dose-response analysis indicated that risk of breast cancer was reduced by 5% per 0.1g/day or 0.1% energy/day increment of dietary marine n-3 PUFA intake.
The authors call for further prospective cohort studies as these findings could have public health implications with regard to prevention of breast cancer through dietary and lifestyle interventions.

* Zheng JS. Intake of fish and marine n-3 polyunsaturated fatty acids and risk of breast cancer: meta-analysis of data from 21 independent prospective cohort studies. British Medical Journal 2013;346:f3706